My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling.

    Vestergaard ET, Gormsen LC, Jessen N, Lund S, Hansen TK, Moller N, Jorgensen JO.

    Diabetes. 2008 Dec;57(12):3205-10. Epub 2008 Sep 5.PMID: 18776138 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Acute effects of ghrelin administration on glucose and lipid metabolism.

    Vestergaard ET, Djurhuus CB, Gjedsted J, Nielsen S, Møller N, Holst JJ, Jørgensen JO, Schmitz O.

    J Clin Endocrinol Metab. 2008 Feb;93(2):438-44. Epub 2007 Nov 27.PMID: 18042651 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis.

    Vestergaard ET, Hansen TK, Nielsen S, Moller N, Christiansen JS, Jorgensen JO.

    Eur J Endocrinol. 2005 Oct;153(4):545-9. Erratum in: Eur J Endocrinol. 2005 Nov;153(5):721. PMID: 16189176 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion.

    Jessen N, Djurhuus CB, Jørgensen JO, Jensen LS, Møller N, Lund S, Schmitz O.

    Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E194-9. Epub 2004 Aug 31.PMID: 15339744 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans.

    Broglio F, Prodam F, Riganti F, Gottero C, Destefanis S, Granata R, Muccioli G, Abribat T, van der Lely AJ, Ghigo E.

    J Endocrinol Invest. 2008 Sep;31(9):788-94.PMID: 18997491 [PubMed - indexed for MEDLINE]Related articles

    6.

    Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.

    Nielsen C, Gormsen LC, Jessen N, Pedersen SB, Møller N, Lund S, Jørgensen JO.

    J Clin Endocrinol Metab. 2008 Jul;93(7):2842-50. Epub 2008 May 6.PMID: 18460563 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.

    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.

    Eur J Endocrinol. 2003 Dec;149(6):511-9.PMID: 14640991 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.

    Garcia JM, Polvino WJ.

    Growth Horm IGF Res. 2009 Jun;19(3):267-73. Epub 2009 Feb 3.PMID: 19196529 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of morning cortisol replacement on glucose and lipid metabolism in GH-treated subjects.

    Segerlantz M, Bramnert M, Thomasson R, Manhem P, Laurila E, Groop LC.

    Eur J Endocrinol. 2004 Dec;151(6):701-7.PMID: 15588236 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.

    Broglio F, Gottero C, Benso A, Prodam F, Casanueva FF, Dieguez C, van der Lely AJ, Deghenghi R, Arvat E, Ghigo E.

    Clin Endocrinol (Oxf). 2003 Jan;58(1):92-8.PMID: 12519418 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impact of fasting on growth hormone signaling and action in muscle and fat.

    Moller L, Dalman L, Norrelund H, Billestrup N, Frystyk J, Moller N, Jorgensen JO.

    J Clin Endocrinol Metab. 2009 Mar;94(3):965-72. Epub 2008 Dec 9.PMID: 19066303 [PubMed - indexed for MEDLINE]Related articles

    12.

    Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.

    Broglio F, Prodam F, Gottero C, Destefanis S, Me E, Riganti F, Giordano R, Picu A, Balbo M, Van der Lely AJ, Ghigo E, Arvat E.

    Clin Endocrinol (Oxf). 2004 Jun;60(6):699-704.PMID: 15163333 [PubMed - indexed for MEDLINE]Related articles

    13.

    Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.

    Damjanovic SS, Lalic NM, Pesko PM, Petakov MS, Jotic A, Miljic D, Lalic KS, Lukic L, Djurovic M, Djukic VB.

    J Clin Endocrinol Metab. 2006 Jul;91(7):2574-81. Epub 2006 Apr 18.PMID: 16621911 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients.

    Dall R, Kanaley J, Hansen TK, Møller N, Christiansen JS, Hosoda H, Kangawa K, Jørgensen JO.

    Eur J Endocrinol. 2002 Jul;147(1):65-70.PMID: 12088921 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.

    Di Vito L, Broglio F, Benso A, Gottero C, Prodam F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Ghigo E, Arvat E.

    Clin Endocrinol (Oxf). 2002 May;56(5):643-8.PMID: 12030916 [PubMed - indexed for MEDLINE]Related articles

    16.

    Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses.

    Leal-Cerro A, Torres E, Soto A, Dios E, Deghenghi R, Arvat E, Ghigo E, Dieguez C, Casanueva FF.

    Neuroendocrinology. 2002 Dec;76(6):390-6.PMID: 12566947 [PubMed - indexed for MEDLINE]Related articles

    17.

    The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.

    Broglio F, Gianotti L, Destefanis S, Fassino S, Abbate Daga G, Mondelli V, Lanfranco F, Gottero C, Gauna C, Hofland L, Van der Lely AJ, Ghigo E.

    Clin Endocrinol (Oxf). 2004 May;60(5):592-9.PMID: 15104562 [PubMed - indexed for MEDLINE]Related articles

    18.

    RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.

    Garrel DR, Moussali R, De Oliveira A, Lesiège D, Larivière F.

    J Clin Endocrinol Metab. 1995 Feb;80(2):379-85.PMID: 7888013 [PubMed - indexed for MEDLINE]Related articles

    19.

    Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.

    Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E.

    J Clin Endocrinol Metab. 2001 Mar;86(3):1169-74.PMID: 11238504 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations.

    Lucidi P, Murdolo G, Di Loreto C, Parlanti N, De Cicco A, Fatone C, Taglioni C, Fanelli C, Broglio F, Ghigo E, Bolli GB, Santeusanio F, De Feo P.

    Nutr Metab Cardiovasc Dis. 2005 Dec;15(6):410-7. Epub 2005 Oct 20.PMID: 16314227 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity